Centre grants approval to bulk drug park at Haroli in Una district.

September 1, 2022

The Union Ministry of Chemicals and Fertilisers has finally granted in-principle approval for providing grant-in-aid for a bulk drug park proposed at Haroli in Una district.
This will give a major boost to the state’s pharma sector which accounts for 40 per cent of nation’s drug formulations. Annual demand of bulk drugs in the state is about Rs 30,000 to Rs 35,000 crore.
The setting up of the Bulk Drug Pharma Park at Una would help reduce India’s dependency on China for raw material for producing various drugs.
According to CM, there is almost 100 per cent dependence on China for raw material required for producing erythromycin and norfloxin, 95 per cent for producing tetracycline and 68 per cent for making betadine B 12 drugs. So, setting up of a drug park will help reduce dependence on China.
He said that the government had made serious efforts for the bulk drug pharma park, as Baddi was the biggest pharma hub in Asia.
He said the pharma park would attract Rs 50,000 crore investment, besides creating employment for 20,000 people and 10,000 indirect jobs.
“The approval was granted primarily due to the fact that we had spelt out several incentives like Rs 3 per unit rate of power for 10 years, zero maintenance charges for 10 years, exemption in stamp duty and 70 per cent exemption in the SGST for 10 years.
Thakur said 1,405 acres would be required for the project, including 1,366 acres of the government and 39 acres belonging to private parties. The total projects cost would be Rs 1,190 crore.
The Central government would provide grant-in-aid of Rs 1,000 crore while the state government would provide Rs 190 crore.